Compare Gilead Sciences, Inc. (GILD) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Roblox Corp — how do they compare? Gilead Sciences, Inc. trades at $133.38 (market cap $163.51B), while Roblox Corp trades at $56.34 (market cap $40.86B). The key difference: Gilead Sciences, Inc. is far larger — about 4× Roblox Corp's market cap, and Gilead Sciences, Inc. pays a 2.49% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| GILD | RBLX | |
|---|---|---|
Market Cap | $163.51B | $40.86B |
Sector | Health | Media |
52-Week High | $155.80 | $141.56 |
52-Week Low | $108.22 | $41.30 |
Enterprise Value | $178.05B | $39.45B |
Dividend Yield | 2.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $130.04, down 1.04% on the day, with technical indicators showing a bearish bias while fundamentals remain strong. The company has beaten earnings expectations for three consecutive quarters, maintains robust profitability with a 30.99% net income margin, and recently secured FDA and European Commission approvals for expanded use of its oncology drug Trodelvy. Analyst consensus remains overwhelmingly positive with a $152.83 price target representing 17.5% upside potential.
The outlook for GILD is favorable with strong earnings momentum, expanding oncology portfolio, and solid cash generation, though risks include patent expirations, competitive pressures in HIV treatments, and recent negative cash flow trends. The stock presents a compelling opportunity for investors seeking exposure to a profitable biopharmaceutical company with growth catalysts, supported by Wall Street's bullish sentiment and recent regulatory wins.
Roblox (RBLX) trades at $54.47, down 1.12% on the day, with a bullish technical signal from moving averages despite neutral oscillators. The company shows strong revenue growth, reaching $4.89B in 2025, but continues to report significant net losses (-$1.07B). Analyst consensus is positive with a $59.62 price target, though multiple class action lawsuits create near-term legal overhang. Operating cash flow improved to $1.8B in 2025, supporting ongoing platform investments.
RBLX presents a growth-at-a-value story with robust user monetization potential offset by persistent profitability challenges. The stock offers upside to analyst targets but faces execution risks from legal proceedings and the need to translate revenue growth into sustainable earnings. Investor focus remains on Q3 2026 DAU recovery and margin improvement prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
